Guardian Wealth Management LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the first quarter, HoldingsChannel reports. The fund purchased 6,406 shares of the conglomerate’s stock, valued at approximately $1,215,000. Danaher accounts for approximately 0.4% of Guardian Wealth Management LLC’s portfolio, making the stock its 21st largest holding.
Several other institutional investors have also bought and sold shares of the business. Sivia Capital Partners LLC increased its stake in Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock worth $397,000 after acquiring an additional 119 shares during the last quarter. First Trust Advisors LP lifted its stake in shares of Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after purchasing an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC boosted its holdings in shares of Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock worth $610,000 after purchasing an additional 886 shares during the period. Ieq Capital LLC boosted its holdings in shares of Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock worth $14,957,000 after purchasing an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC increased its position in shares of Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
DHR opened at $195.67 on Monday. The business has a fifty day moving average of $178.81 and a 200 day moving average of $201.53. The stock has a market cap of $138.49 billion, a P/E ratio of 37.85, a PEG ratio of 2.50 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Evercore raised their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 21st. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research report on Friday, April 17th. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. The Goldman Sachs Group lowered their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $233.61.
Check Out Our Latest Analysis on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
